Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pankti Mehta

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Rheumatology International|August 31, 2023
Efficacy and safety of curcumin in maintaining remission during disease-modifying antirheumatic drug withdrawal in rheumatoid arthritis at 52 weeks: a phase III double-blind, randomized placebo-controlled trialSreeja S Bhat, Sakir Ahmed, Reshma Reji, et al.
The Lancet. Rheumatology|November 2, 2022
Withholding methotrexate after vaccination with ChAdOx1 nCov19 in patients with rheumatoid or psoriatic arthritis in India (MIVAC I and II): results of two, parallel, assessor-masked, randomised controlled trialsTeny Grace Skaria, Anu Sreeprakash, Rashwith Umesh, et al.
International Journal of Rheumatic Diseases|September 20, 2024
Myositis India: Early lessons from a patient support group in a resource-limited settingAnushka Aggarwal, Narendra Kumar Bagri, Chengappa Kavadichanda, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Rheumatology International|August 31, 2023
Efficacy and safety of curcumin in maintaining remission during disease-modifying antirheumatic drug withdrawal in rheumatoid arthritis at 52 weeks: a phase III double-blind, randomized placebo-controlled trialSreeja S Bhat, Sakir Ahmed, Reshma Reji, et al.
The Lancet. Rheumatology|November 2, 2022
Withholding methotrexate after vaccination with ChAdOx1 nCov19 in patients with rheumatoid or psoriatic arthritis in India (MIVAC I and II): results of two, parallel, assessor-masked, randomised controlled trialsTeny Grace Skaria, Anu Sreeprakash, Rashwith Umesh, et al.
International Journal of Rheumatic Diseases|September 20, 2024
Myositis India: Early lessons from a patient support group in a resource-limited settingAnushka Aggarwal, Narendra Kumar Bagri, Chengappa Kavadichanda, et al.
Pageof 7